GeneDx And Zevra Therapeutics Announce New Genetic Testing Program To Detect Niemann-Pick Disease Type C

GeneDx Holdings Corp. Class A -8.45% Pre
Zevra Therapeutics, Inc. +1.25% Pre

GeneDx Holdings Corp. Class A

WGS

60.05

60.05

-8.45%

0.00% Pre

Zevra Therapeutics, Inc.

ZVRA

9.71

9.71

+1.25%

0.00% Pre
GeneDx And Zevra Therapeutics Announce New Genetic Testing Program To Detect Niemann-Pick Disease Type C